黄玮,李爱凌,顾俊

• 1:重庆医科大学附属第一医院心内科

摘要(Abstract)：

本文介绍侵入性心肺运动试验(iCPET)在早期肺动脉高压(PAH)中的诊断价值。早期诊断并得到有效治疗的PAH患者远期生存率远高于中晚期诊断的PAH患者。iCPET可诊断运动诱发的肺动脉高压(ePAH)。文中介绍了iCPET的诊断流程和操作方法以及ePAH的诊断标准。近年越来越多的证据表明ePAH很可能为早期PAH。因此,iCPET对于诊断早期PAH有重要的价值,期待得到临床医师的关注和应用。

关键词(KeyWords)： 侵入性心肺运动试验;肺动脉高压;运动诱发的肺动脉高压;疑难呼吸困难

Abstract:

Keywords:

基金项目(Foundation): 重庆市中青年医学高端人才工作室项目（ZQNYXGDRCGZS2019001）;; 重庆市卫生健康委医学科研计划项目（2016HBRC001）

作者(Author): 黄玮,李爱凌,顾俊

参考文献(References)：

• [1]Jing ZC,Xu XQ,Han ZY,et al.Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.Chest,2007,132(2):373-379.
• [2]Humbert M,Sitbon O,Chaouat A,et al.Pulmonary arterial hypertension in France:results from a national registry.Am J Respir Crit Care Med,2006,173(9):1023-1030.
• [3]Strange G,Gabbay E,Kermeen F,et al.Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension:The delay study.Pulm Circ,2013,3(1):89-94.
• [4]高强，徐巍，王定宇，等.肺动脉高压介入治疗研究进展.中国介入心脏病学杂志，2020,28(11):644-646.
• [5]Huang W,Resch S,Oliveira RK,et al.Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea:Insights from a multidisciplinary dyspnea center.Eur J Prev Cardiol,2017,24(11):1190-1199.
• [6]Maron BA,Cockrill BA,Waxman AB,et al.The invasive cardiopulmonary exercise test.Circulation,2013,127(10):1157-1164.
• [7]洪城，张挪富，高怡，等.侵入性心肺运动试验临床应用二例.中华结核和呼吸杂志，2019,42(1):65-66.
• [8]李卓霖，何杨柯，向涯洁，等.侵入性心肺运动试验诊断不明原因呼吸困难患者的病例分析.四川大学学报（医学版），2021,52(1):142-114.
• [9]Oldham WM,Lewis GD,Opotowsky AR,et al.Unexplained exertional dyspnea caused by low ventricular fi lling pressures:results from clinical invasive cardiopulmonary exercise testing.Pulm Circ,2016,6(1):55-62.
• [10]Huang W,Systrom D,Waxman A.The long-term outcomes in patients with exercise-induced pulmonary arterial hypertension.Am JRespir Crit Care Med,2016,193:A7317.
• [11]Singh I,Oliveira RKF,Naeije R,et al.Pulmonary vascular distensibility and early pulmonary vascular remodeling in pulmonary hypertension.Chest,2019,156(4):724-732.
• [12]Kohli P,Kelly VJ,Kehl EG,et al.Perfusion imaging distinguishes exercise pulmonary arterial hypertension at rest.Am J Respir Crit Care Med,2019,199(11):1438-1441.
• [13]Sanders JL,Han Y,Urbina MF,et al.Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension.Pulm Circ,2019,9(4):2045894019882623.
• [14]Oliveira RKF,Faria-Urbina M,Maron BA,et al.Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure.Pulm Circ,2017,7(3):654-665.
• [15]Segrera SA,Lawler L,Opotowsky AR,et al.Open label study of ambrisentan in patients with exercise pulmonary hypertension.Pulm Circ,2017,7(2):531-538.